Immune Responses and Protection of Aotus Monkeys Immunized with Irradiated Plasmodium vivax Sporozoites
Author(s) -
Alejandro Jordán-Villegas,
Jesus Hernandez Lopez,
Thomas L. Richie,
Sócrates Herrera,
Anilza Bonelo Perdomo,
Liliana Soto,
Fabián Méndez,
Alejandro Castellanos,
Stephen L. Hoffman,
María R. Manzano,
Myriam ArévaloHerrera,
Miguel Ángel Hernández-Martínez,
Judith E. Epstein
Publication year - 2011
Publication title -
american journal of tropical medicine and hygiene
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.015
H-Index - 151
eISSN - 1476-1645
pISSN - 0002-9637
DOI - 10.4269/ajtmh.2011.09-0759
Subject(s) - plasmodium vivax , circumsporozoite protein , biology , immune system , malaria , virology , immunization , immunology , immunity , antibody , vaccination , antigen , plasmodium (life cycle) , malaria vaccine , plasmodium falciparum , parasite hosting , computer science , world wide web
A non-human primate model for the induction of protective immunity against the pre-erythrocytic stages of Plasmodium vivax malaria using radiation-attenuated P. vivax sporozoites may help to characterize protective immune mechanisms and identify novel malaria vaccine candidates. Immune responses and protective efficacy induced by vaccination with irradiated P. vivax sporozoites were evaluated in malaria-naive Aotus monkeys. Three groups of six monkeys received two, five, or ten intravenous inoculations, respectively, of 100,000 irradiated P. vivax sporozoites; control groups received either 10 doses of uninfected salivary gland extract or no inoculations. Immunization resulted in the production low levels of antibodies that specifically recognized P. vivax sporozoites and the circumsporozoite protein. Additionally, immunization induced low levels of antigen-specific IFN-γ responses. Intravenous challenge with viable sporozoites resulted in partial protection in a dose-dependent manner. These findings suggest that the Aotus monkey model may be able to play a role in preclinical development of P. vivax pre-erythrocytic stage vaccines.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom